Controlled Trials of Immunosuppressive Therapy in Hepatitis

Postgraduate Medical Journal - United Kingdom
doi 10.1136/pgmj.50.584.392
Full Text
Abstract

Available in full text

Categories
Medicine
Date
Authors
Publisher

BMJ

Related search

Hepatitis B Reactivation in Patients Receiving Immunosuppressive Therapy: A Hidden Menace

Hepatology International
Hepatology
2017English

Reporting Quality-Of-Life Outcomes in Clinical Trials of Immunosuppressive Therapy in Kidney Transplantation

American Journal of Kidney Diseases
Nephrology
2016English

Immunosuppressive Therapy for Indeterminate Acute Hepatitis or Pediatric Acute Liver Failure

Journal of Pediatrics
Child HealthPediatricsPerinatology
2019English

Efficacy and Safety of Immunosuppressive Therapy in the Treatment of Seronegative Hepatitis Associated Aplastic Anemia

Drug Design, Development and Therapy
Drug DiscoveryPharmacologyPharmaceutical Science
2014English

Antiviral Therapy for Prevention of Hepatocellular Carcinoma in Chronic Hepatitis C: Systematic Review and Meta-Analysis of Randomised Controlled Trials

BMJ Open
Medicine
2012English

Beneficial Effects of Lamivudine on Exacerbation of Hepatitis Due to Immunosuppressive Therapy for Fulminant Hepatitis in a Patient With Hepatitis B Virus Carrier

Nihon Toseki Igakkai Zasshi
2004English

Screening for Hepatitis B in the Immigrant Population and Individuals Who Are in Need of Immunosuppressive Drug Therapy

Baylor University Medical Center Proceedings
Medicine
2015English

Ethics Reporting Practices in Randomized Controlled Trials of Physical Therapy Interventions After Stroke

Archives of Physiotherapy
2018English

Experience of Immunosuppressive Therapy in Partial Liver Transplantation.

Japanese Journal of Clinical Immunology
1991English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy